 |
| Global Lactulose Market Size |
Lactulose is used majorly for the treatment of constipation and hepatic
encephalopathy. It works by retaining more water in the stool and softening it.
The growing prevalence of gastrointestinal disorders such as constipation,
intestinal obstruction is driving the demand for lactulose at a significant
rate. Rising awareness among individuals about maintaining proper digestive
health and availability of innovative lactulose-based formulations are expected
to propel the market growth over the forecast period.
The Global
Lactulose Market Size is estimated to be valued at US$ 201.94 Bn in 2024 and is expected to exhibit a CAGR of 13. % over the forecast period
2024 to 2031.
Key Takeaways:
Key players operating in the lactulose market are Amgen Inc., F. Hoffmann-La
Roche AG., Intas Pharmaceuticals Ltd., AstraZeneca plc, Mylan N.V., Dr. Reddy's
Laboratories, Bristol - Myers Squibb, Merck & Co., Inc.,
BIOCAD-Biotechnology company, Reliance Life Sciences, Biocon Limited, and
Hetero Drugs Limited. These players are focusing on new product launches and
geographical expansion strategies to strengthen their market presence.
There is high potential for market growth in emerging economies owing to rising
health awareness and increasing healthcare expenditure. The key players are
focusing on these regions for tapping new opportunities.
The global expansion strategies adopted by major players include mergers &
acquisitions, partnerships, and collaborations. This allows companies to
enhance production capabilities and distribution networks. For instance, in
2021, Amgen Inc. announced a strategic collaboration with HedgePath
Pharmaceuticals to develop and commercialize therapies for difficult-to-treat
cancers.
Market drivers:
The increasing prevalence of gastrointestinal disorders and growing geriatric
population are major market drivers. Constipation and hepatic encephalopathy
are highly prevalent among the aged population which is fueling the product
demand. Innovative product offerings with improved formulations and
multi-functional benefits are further augmenting the industry growth.
Market restrain:
The availability of alternative treatment options for gastrointestinal
disorders and stringent regulatory guidelines for new drug approvals are the
key market restraints. Alternative synthetic medications and herbal
alternatives also impede the market progression to some extent.
Segment Analysis
Lactulose market is segmented into prescription and OTC. The prescription
segment is the dominating sub segment due to increasing preference for
lactulose syrup and tablets among patients suffering from hepatic
encephalopathy and constipation. These prescription based lactulose drugs offer
accurate dosing and consistent results.
Global Analysis
Regionally, North America holds the largest share in the global lactulose
market owing to increasing prevalence of hepatic encephalopathy and
constipation diseases. Asia Pacific is expected to grow at the fastest rate
during the forecast period due to rising awareness regarding lactulose products
and increasing healthcare expenditure in emerging economies like China and
India. Additionally, strategic initiatives by key players to expand their
footprint in Asia Pacific further boost the market growth.
Get More
Insights On This Topic: Lactulose
Market